Katsuya Inagaki

Title: Katsuya Inagaki: Innovator in Recombinant Baculovirus Vaccines

Introduction

Katsuya Inagaki is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. With a total of 2 patents, Inagaki's work focuses on innovative solutions for infectious diseases.

Latest Patents

Inagaki's latest patents revolve around a recombinant baculovirus vaccine. This invention provides a novel transfer vector and a recombinant baculovirus, along with methods for their production. The pharmaceuticals developed from this invention contain the recombinant baculovirus as an active ingredient, which is useful as preventive or therapeutic drugs for infectious diseases such as malaria and influenza. More specifically, the invention includes a recombinant transfer vector capable of expressing a foreign gene fused to a virus gene under the control of a dual promoter. The methods for preventing and treating infectious diseases involve administering the recombinant baculovirus to patients.

Career Highlights

Throughout his career, Katsuya Inagaki has worked with notable organizations, including the Educational Foundation Jichi Medical University and Otsuka Pharmaceutical Company, Limited. His experience in these institutions has contributed to his expertise in vaccine development and biotechnology.

Collaborations

Inagaki has collaborated with esteemed colleagues such as Shigeto Yoshida and Masanori Kawasaki. These partnerships have further enhanced his research and innovation in the field.

Conclusion

Katsuya Inagaki's contributions to the development of recombinant baculovirus vaccines highlight his role as an influential inventor in biotechnology. His work continues to pave the way for advancements in preventive medicine against infectious diseases.